bupropion has been researched along with ketamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abelaira, HM; Borba, LA; Botelho, MEM; de Moura, AB; Fileti, ME; Garbossa, L; Goldim, MP; Gonçalves, CL; Ignácio, ZM; Petronilho, F; Quevedo, J; Réus, GZ; Rosa, T; Veron, DC | 1 |
| Kennedy, S; Lapointe, T; Leatham, Z; Leri, F; Melanson, B; Wolter, M | 1 |
| Orsolini, L; Salvi, V; Volpe, U | 1 |
| Cook, J; Halaris, A | 1 |
| Chaki, S; Watanabe, M | 1 |
3 review(s) available for bupropion and ketamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Craving and addictive potential of esketamine as side effects?
Topics: Adult; Bupropion; Craving; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ketamine | 2022 |
Antidepressants in the post-ketamine Era: Pharmacological approaches targeting the glutamatergic system.
Topics: Antidepressive Agents; Bupropion; Depression; Drug Discovery; Ketamine; United States | 2023 |
5 other study(ies) available for bupropion and ketamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.
Topics: Animals; Antidepressive Agents; Bupropion; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Fluoxetine; Ketamine; Male; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar | 2021 |
Conditioned anti-immobility by ketamine: A comparison to escitalopram and bupropion.
Topics: Animals; Antidepressive Agents; Bupropion; Escitalopram; Ketamine; Male; Rats; Rats, Sprague-Dawley | 2023 |
Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression.
Topics: Bupropion; Depression; Depressive Disorder, Treatment-Resistant; Dopamine; Humans; Ketamine; N-Methylaspartate | 2022 |